Screener
ClearPoint Neuro CLPT EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from ClearPoint Neuro’s reported figures.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
FAQ
- What is ClearPoint Neuro's EBITDA?
- ClearPoint Neuro (CLPT) reported EBITDA of -$8.39M in Q1 2026.
- How has ClearPoint Neuro's EBITDA changed year-over-year?
- ClearPoint Neuro's EBITDA decreased by 38.5% year-over-year, from -$6.06M to -$8.39M.
- What is the long-term trend for ClearPoint Neuro's EBITDA?
- Over 4 years (2021 to 2025), ClearPoint Neuro's EBITDA has grown at a 15.3% compound annual growth rate (CAGR), from -$13.22M to -$23.35M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about ClearPoint Neuro's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude